Lametec 25 DT Tablet contains Lamotrigine 25 mg, an antiepileptic medication primarily used in the management of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and inhibiting the release of excitatory neurotransmitters through modulation of voltage-sensitive sodium channels. This mechanism helps in controlling seizures and mood swings. Lametec 25 DT is indicated for the treatment of partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, it is prescribed as a mood stabilizer in bipolar disorder to delay the occurrence of mood episodes. The tablet is designed as a dispersible tablet, facilitating ease of administration, particularly in patients with swallowing difficulties. Dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize the risk of serious skin reactions such as Stevens-Johnson syndrome. Common adverse effects include dizziness, headache, blurred vision, and nausea. Caution is advised in patients with hypersensitivity to Lamotrigine or its components, and it should be used under strict medical supervision, especially when combined with other antiepileptic drugs. Regular monitoring is essential to ensure therapeutic efficacy and safety during treatment with Lametec 25 DT Tablet.